Graff GR - Search Results

1

Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?

Geskey JM, Ceneviva GD, Brummel GL, Graff GR, Javier MC. Geskey JM, et al. Among authors: graff gr. Clin Ther. 2004 Dec;26(12):2130-7. doi: 10.1016/j.clinthera.2004.12.005. Clin Ther. 2004. PMID: 15823776 Review.

2

Pulmonary arteriovenous malformation: an unusual case of hypoxemia in an infant.

Geskey JM, Waterfield M, Weber HS, Graff GR. Geskey JM, et al. Among authors: graff gr. Clin Pediatr (Phila). 2005 Apr;44(3):263-6. doi: 10.1177/000992280504400311. Clin Pediatr (Phila). 2005. PMID: 15821852 No abstract available.

3

Palivizumab and Long-term Outcomes in Cystic Fibrosis.

Fink AK, Graff G, Byington CL, Loeffler DR, Rosenfeld M, Saiman L. Fink AK, et al. Pediatrics. 2019 Jul;144(1):e20183495. doi: 10.1542/peds.2018-3495. Pediatrics. 2019. PMID: 31239289

4

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.

Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D. Graff GR, et al. Clin Ther. 2010 Jan;32(1):89-103. doi: 10.1016/j.clinthera.2010.01.012. Clin Ther. 2010. PMID: 20171415 Clinical Trial.

5

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators. Mayer-Hamblett N, et al. Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2. Pediatr Pulmonol. 2013. PMID: 23818295 Free PMC article. Clinical Trial.

6

Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.

Graff GR, McNamara J, Royall J, Caras S, Forssmann K. Graff GR, et al. Clin Drug Investig. 2010;30(6):351-64. doi: 10.2165/11533390-000000000-00000. Clin Drug Investig. 2010. PMID: 20441244 Clinical Trial.

7

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis.

Konstan MW, Accurso FJ, Nasr SZ, Ahrens RC, Graff GR. Konstan MW, et al. Among authors: graff gr. Clin Investig (Lond). 2013 Aug 1;3(8):723-729. doi: 10.4155/cli.13.62. Clin Investig (Lond). 2013. PMID: 25210613 Free PMC article.

8

Montelukast pharmacokinetics in cystic fibrosis.

Graff GR, Weber A, Wessler-Starman D, Smith AL. Graff GR, et al. J Pediatr. 2003 Jan;142(1):53-6. doi: 10.1067/mpd.2003.mpd0332. J Pediatr. 2003. PMID: 12520255

9

Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.

Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. Trapnell BC, et al. Among authors: graff gr. J Cyst Fibros. 2009 Dec;8(6):370-7. doi: 10.1016/j.jcf.2009.08.008. Epub 2009 Oct 7. J Cyst Fibros. 2009. PMID: 19815466 Free article. Clinical Trial.

10

Radiological case of the month. Pulmonary aplasia.

Graff GR, Beckerman RC. Graff GR, et al. Arch Pediatr Adolesc Med. 1997 Jul;151(7):737-8. doi: 10.1001/archpedi.1997.02170440099017. Arch Pediatr Adolesc Med. 1997. PMID: 9232051 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page